亦立医药-亦立为光，生命为核

Light for Life, Core to Hope

ELI Radiopharma is dedicated to innovative radiopharmaceutical theranostics for oncology and neurological diseases to address unmet clinical needs worldwide.

Our Focus

01/03
02/03
03/03

Driven by Breakthrough Efficacy
Advancing Hope for Life
Innovating for the Future

Driven by Breakthrough Efficacy

We innovate precision-targeted radiopharmaceuticals, integrating diagnosis and therapy to transform patient outcomes.
Advancing Hope for Life

We drive R&D through technological innovation and rigorous quality control to anchor radiopharmaceutical development in real clinical needs.
Innovating for the Future

Driven by original innovation, we advance radiopharmaceutical R&D and deliver safer, more effective theranostic solutions to advance the future of clinical care.

Our Team

Team

A multidisciplinary, globally experienced team driving innovation in radiopharmaceuticals.

Our Science

Pipeline

We develop targeted theranostic solutions for neurodegenerative diseases and oncology to address global unmet clinical needs.

Neurological diseases Diagnosis

Innovative diagnostic tracers for Alzheimer's disease (AD) and Parkinson's disease (PD), delivering high diagnostic confidence and cost-effective solutions.
Targeted Oncology Theranostics

We develop tumor-targeted radiopharmaceuticals with theranostic potential, using advanced ligand screening and platform technologies to deliver precise solutions for solid tumors.

Press Release

ELI Radiopharma advances innovative radiopharmaceuticals for oncology and neurological diseases, delivering R&D breakthroughs as patient-oriented solutions.

Light for Life, Core to Hope

Our Focus

Our Team

Our Science

Press Release

Life Renewed, Future Illuminated